RhythmScience
RhythmScience provides the cloud-based Rhythm360 platform that aggregates cardiac device data (implantable, wearable, EKG, heart failure therapy) into a single workflow for U.S. cardiology practices, health systems, and hospitals, with bidirectional EHR integration and an exclusive Cedars-Sinai-licensed HF-AI algorithm.
- Company typePrivate
- Founded2019
- HeadquartersSan Francisco, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What RhythmScience does
RhythmScience is a U.S.-based healthcare technology company that operates Rhythm360, a cloud-based cardiac data management platform serving cardiology practices, health systems, hospitals, and clinics across the United States. Founded in 2019 and headquartered in San Francisco with an additional office in New York, the company aggregates data from implantable cardiac devices (pacemakers, ICDs, loop recorders), ambulatory cardiac monitors (MCOTs, EKG patches), wearable devices, and heart failure therapy devices (CVRx Barostim, Impulse Dynamics Optimizer) into a single vendor-neutral dashboard. The platform integrates bidirectionally with major EHR systems (Epic, Cerner, GE Centricity, eClinicalWorks, Greenway Health, Providence) via HL7 and SMART on FHIR APIs, and is SOC 2 Type 1 certified and HIPAA compliant.
RhythmScience firmographics
Firmographics- Name
- RhythmScience
- Legal name
- RhythmScience Inc.
- Website
- https://rhythm360.io
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- RhythmScience provides the cloud-based Rhythm360 platform that aggregates cardiac device data (implantable, wearable, EKG, heart failure therapy) into a single workflow for U.S. cardiology practices, health systems, and hospitals, with bidirectional EHR integration and an exclusive Cedars-Sinai-licensed HF-AI algorithm.
- Ownership category
- akta.pro rank
RhythmScience industry classification
Industry- Product category
- Cardiology Data Management Software
- NAICS
- Computer Systems Design and Related Services (54151), Custom Computer Programming Services (541511), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management) (HLALAFAL)
- akta.pro secondary industries
- Cardiology Telemedicine Platforms (HLALAGAB), Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Cardiac Rhythm Management (Pacemakers, ICDs, CRT) (HLAHAFAC), Virtual Nursing, Telemonitoring & Command Center Platforms (HLACAFAH)
Keywords
Where RhythmScience is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
RhythmScience business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Software Platform Subscription: SaaS subscription model for the Rhythm360 platform with software modules (PM for pacemaker monitoring, RPM for remote physiological monitoring). Billed per order form with terms specified in Terms and Conditions. Pricing not publicly disclosed - quote-based.
- Professional Services: Technical services teams supplement existing clinical care teams to provide expert patient engagement services including alert management, patient compliance, and health coaching. Integration services for EHR integration also provided.
- Remote Patient Monitoring Billing: Platform supports and streamlines billing for remote monitoring CPT codes including 93294-93298 (pacemakers, defibrillators, implantable cardiac monitors, loop recorders) and RPM codes. Maximizes billable revenues for providers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Customized pricing based on clinic needs |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels6 records
RhythmScience product offering
Product offeringCore offering
RhythmScience provides the Rhythm360 cloud-based cardiac data management platform that aggregates data from implanted cardiac devices, wearables, and at-home connected devices into a single unified workspace. The platform supports hypertension management, heart failure monitoring, and cardiac rhythm management (CIEDs, MCOTs, EKGs) for cardiology practices, health systems, and hospitals. It includes the exclusively licensed Cedars-Sinai HF-AI algorithm, bidirectional EHR integrations, and is complemented by a clinically trained Patient Care Team for patient engagement, alert management, and compliance coaching.
Product overview
RhythmScience offers Rhythm360 as its flagship cloud-based platform for comprehensive cardiac data management, supporting hypertension, heart failure, and rhythm disorder monitoring. The platform includes two core software modules: the PM (Pacemaker Monitoring) module for implantable cardiac device data, and the RPM (Remote Physiological Monitoring) module for wearable device data. The product portfolio also includes a mobile app (Rhythm360 for Providers) and optional clinically-trained patient engagement services. The platform integrates with major EHR systems and supports data from various cardiac devices including pacemakers, ICDs, loop recorders, MCOTs, and 12-lead EKGs.
Differentiator
Problem solved
Functional benefit
Brands
- Rhythm360: Cloud-based cardiac data management platform that provides comprehensive cardiology care for hypertension, heart failure, and rhythm management. Includes patient monitoring, EHR integration, and clinical workflow tools.
Products and services
- Rhythm360 Platform Cloud-based cardiac data management platform that provides a unified workspace to review, interpret, and utilize data from patients and devices for hypertension management, heart failure management, and rhythm management (CIEDs, MCOTs, EKGs). Targets cardiology practices, health systems, hospitals, and clinics across the U.S.
- Rhythm360 for Providers (Mobile App) Cloud-based universal cardiac data mobile application for implanted devices, wearables, and at-home connected devices. Enables clinicians to incorporate notation, e-signing, and billing into everyday workflows for managing cardiac data. Available on Apple App Store and Google Play Store.
- HF-AI Algorithm (Heart Failure AI) Exclusively licensed AI algorithm from Cedars-Sinai that analyzes patient data to provide personalized recommendations for Guideline-Directed Medical Therapy (GDMT). The TURING-HF study demonstrated cardiologists agree with AI treatment recommendations 90.8% of the time, doubling use of lifesaving heart failure medications and leading to a 74% reduction in hospitalizations.
- Patient Care Team Services Clinically trained patient engagement team that supplements existing clinical care teams with expert patient engagement services including alert management, patient compliance monitoring, and health coaching. Available as an extension of clinical staff for cardiology practices and health systems.
Quantifiable outcome
- 74% reduction in hospitalizations with HF-AI algorithm use
- +2 more outcomes
Companies that use RhythmScience
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles2 records
RhythmScience technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration9 records
AI capability4 records
Feature7 records
RhythmScience partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core, key and supporting.
- Cedars-Sinai (Technology Ventures)coreExclusive licensing agreement for the HF-AI (Heart Failure AI) algorithm invented by Dr. Raj Khandwalla from Cedars-Sinai's Smidt Heart Institute. The algorithm optimizes Guideline-Directed Medical Therapy for heart failure patients. Building on existing strategic relationship with Cedars-Sinai Health Ventures as lead Series A investor. Dr. Khandwalla serves as medical director of Cedars-Sinai Technology Ventures.
- MedAxiomkeyIndustry partnership with MedAxiom, the cardiovascular community's premier source for organizational performance solutions and an American College of Cardiology Company. Partnership aims to drive transformative changes in cardiovascular care and expand RhythmScience's footprint in the cardiac data market. MedAxiom combines knowledge of hundreds of cardiovascular organization members with proprietary tools and smart data.
- QT MedicalkeyPartnership that transforms EKG monitoring for cardiac clinics by integrating QT Medical's hospital-grade 12-lead EKG devices into the Rhythm360 platform. Diagnostic data is wirelessly transmitted to the Rhythm360 portal. The EKG device is ordered through the provider's Rhythm360 portal and mailed directly to patients.
- EpickeyBidirectional EHR integration via HL7 and Smart on FHIR APIs. Listed on Epic Showroom (listing ID 150) for ambulatory cardiac monitoring integration. Version 1.1 released for Epic integration.
- CernersupportingBidirectional EHR integration with Cerner for streamlined reporting, automated billing, and centralized patient information.
- GE CentricitysupportingEHR integration partnership with GE Centricity for cardiac data management and workflow automation.
- eClinical WorkssupportingEHR integration with eClinical Works for streamlined cardiac data management.
- Greenway HealthsupportingEHR integration with Greenway Health for cardiology data management.
- ProvidencesupportingIntegration partnership with Providence health system for cardiac data management.
- Torrance MemorialsupportingIntegration partnership with Torrance Memorial Medical Center, a Cedars-Sinai Affiliate.
- CVRxsupportingPlatform expansion to support CVRx Barostim device data integration for heart failure management. Barostim provides targeted treatment for heart failure with reduced ejection fraction by stimulating baroreceptors.
- Impulse DynamicssupportingPlatform expansion to support Impulse Dynamics Optimizer Smart Mini device for Cardiac Contractility Modulation (CCM) therapy in heart failure patients.
Scale indicators5 records
Recent moves7 records
Expansion highlights5 records
RhythmScience competitors and assessment
Company assessmentBroad incumbents
- Preventice Solutions (Boston Scientific): Now part of Boston Scientific, Preventice provides BodyGuardian remote cardiac monitoring services and a clinician portal, offering an incumbent alternative to Rhythm360 with deeper device-side integration through its parent.
- BioTel (Philips Remote Cardiac Monitoring): Philips-owned BioTel provides cardiac telemetry, Holter, and event monitoring services with a clinician portal, competing as a larger, established vendor in the same cardiology remote monitoring workflow.
- Hicuity Health: Hicuity (formerly Advanced ICU Care) provides virtual nursing, tele-monitoring and command-center services that overlap with RhythmScience's Virtual Nursing and Patient Care Team offering.
Direct peers
- Vector Remote Care: Vector provides remote cardiac monitoring services and a software platform aggregating implantable and wearable cardiac device data, with very similar clinical staffing and cardiology practice go-to-market to RhythmScience.
- iRhythm Technologies: iRhythm's Zio long-term cardiac monitor and its ECG analytics platform compete with RhythmScience's ambulatory cardiac monitoring and rhythm management modules, targeting the same cardiology end-users.
- InfoBionic (now Stryker: QALM): InfoBionic offers a cloud-based cardiac RPM platform (MoMe ARC) for ambulatory ECG and arrhythmia monitoring, competing head-to-head with Rhythm360 in cardiology practices and hospital outpatient settings.
- PaceMate: PaceMate is a direct competitor offering cloud-based cardiac device data monitoring and EHR-integrated workflows for CIEDs and ambulatory monitors, targeting the same cardiology practice and health system buyers with a similar vendor-neutral positioning.
Emerging players
- Vivante Health: Vivante is a digital health platform focused on multi-condition chronic care management including cardiovascular risk, adjacent to RhythmScience's HF/HTN care pathways and RPM modules.
- Vivify Health (Optum): Vivify Health offers a device-agnostic RPM and care management platform covering multiple chronic conditions including cardiology, overlapping with Rhythm360's multi-condition RPM and care orchestration positioning.
- Health Recovery Solutions: HRS provides a tablet-based RPM platform with cardiovascular condition kits, competing for the same multi-condition RPM budget at cardiology practices and home health agencies.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
RhythmScience social profiles
Digital presenceRhythmScience compliance and trust
Trust signalCompliance2 records
RhythmScience financial estimates
Financial estimateRevenue estimate
Valuation estimate
RhythmScience leadership team
Management profileNumber of profiles
Profiles13 records
RhythmScience funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
RhythmScience M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about RhythmScience
What does RhythmScience do?
RhythmScience provides the Rhythm360 cloud-based cardiac data management platform that aggregates data from implanted cardiac devices, wearables, and at-home connected devices into a single unified workspace. The platform supports hypertension management, heart failure monitoring, and cardiac rhythm management (CIEDs, MCOTs, EKGs) for cardiology practices, health systems, and hospitals. It includes the exclusively licensed Cedars-Sinai HF-AI algorithm, bidirectional EHR integrations, and is complemented by a clinically trained Patient Care Team for patient engagement, alert management, and compliance coaching.
Is RhythmScience a public or private company?
RhythmScience is a private company. It is classified as venture growth investor backed and is currently operating.
When was RhythmScience founded?
RhythmScience was founded in 2019. It employs 51 to 100 people.
Where is RhythmScience based?
RhythmScience is headquartered in San Francisco, United States, in the North America region.
How does RhythmScience make money?
Three revenue lines are on record. Software Platform Subscription is the primary driver. The others are professional Services and remote Patient Monitoring Billing.
Who are RhythmScience's main competitors?
Broad incumbents on record are Preventice Solutions (Boston Scientific), BioTel (Philips Remote Cardiac Monitoring) and Hicuity Health. Direct peers are Vector Remote Care, iRhythm Technologies, InfoBionic (now Stryker: QALM) and PaceMate. Emerging players are Vivante Health, Vivify Health (Optum) and Health Recovery Solutions.
Does RhythmScience have an API?
Yes. The platform integrates with all major EHR vendors via HL7 integrations and advanced API integrations via SMART on FHIR. No public API documentation or developer portal is mentioned on the website.
What industry is RhythmScience in?
RhythmScience's product category is Cardiology Data Management Software. Its primary akta.pro industry code is HLALAFAL, Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management), with a secondary code of HLALAGAB, Cardiology Telemedicine Platforms. Its NAICS code is 54151 and its SIC code is 7372.